| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allovir, Inc. | Chief Scientific Officer | Common Stock | 124,006 | $83,183 | $0.6708 | 02 Feb 2023 | Direct |
| Allovir, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 473,594 | 02 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KLRS | Allovir, Inc. | 16 Aug 2022 | 1 | $0 | 4 | Chief Scientific Officer | 17 Aug 2022, 18:04 |
| KLRS | Allovir, Inc. | 18 Jan 2022 | 6 | $0 | 4 | Chief Scientific Officer | 03 Feb 2023, 16:00 |
| KLRS | Allovir, Inc. | 12 Nov 2021 | 4 | -$465,559 | 4 | Chief Scientific Officer | 16 Nov 2021, 17:36 |
| KLRS | Allovir, Inc. | 10 May 2021 | 1 | -$3,412,500 | 4 | Chief Scientific Officer | 10 May 2021, 17:28 |